Nosa Plugs (NOSA) Q1 2025 earnings summary

Executive summary

• Net sales increased by 50% to 4,233 TSEK compared to the same quarter last year, driven by strong demand in both B2B and B2C channels, especially in Germany and France with over 75% growth in each market.

• Achieved positive operating cash flow for the first time, reflecting improved efficiency and cost control.

• Strategic launches and partnerships in France, Switzerland, Germany, and Benelux, including the rollout of NOSA Nozoil.

Financial highlights

• Net sales: 4,233 TSEK (2,821 TSEK), up 50% year-over-year.

• Operating result (EBIT): -1,320 TSEK (-3,429 TSEK), improved due to higher sales and lower costs.

• EBITDA: -677 TSEK (-3,013 TSEK).

• EPS: -0.01 SEK (-0.02 SEK).

• Operating cash flow: 847 TSEK (-2,730 TSEK).

• Cash and cash equivalents: 4,714 TSEK (14,714 TSEK year ago; 4,314 TSEK at year-end).

• Gross margin: 74% (64%).

Outlook and guidance

• Continued strong momentum expected in Germany and France; further market launches planned in Q2.

• Drug delivery in vivo study underway, with results expected in summer and potential for first pharma partnership.

• Management expects ongoing efficiency improvements and cost savings to support further profitability.